Table 4.
Most important characteristics of macular neovascularization in Group 1 and in Group 2.
| Parameter | Group 1 (VT <8.40) | Group 2 (VT > 8.40) |
|---|---|---|
| Baseline BCVA | 0.63 | 0.28 |
| Baseline CMT | 484 | 380 |
| Final BCVA | 0.24 | 0.43 |
| Final CMT | 362 | 324 |
| Final atrophy | 0% | 30% |
| Speckled fluorescence (n. of quadrants) | 1 | 1.6 |
| MNV/leakage ratio | 0.59 | 0.88 |
| DCP VD | 0.37 | 0.34 |
| Number of injections | 7.2 | 5.2 |